CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity

The molecular technology known as clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) is revolutionizing the field of medical research and deepening our understanding of numerous biological processes. The attraction of CRISPR/Cas9 lies in its ability to effic...

ver descrição completa

Detalhes bibliográficos
Autor principal: Franco-Tormo, María José (author)
Outros Autores: Salas-Crisostomo, Mireille (author), Rocha, Nuno (author), Budde, Henning (author), Machado, Sérgio (author), Murillo-Rodríguez, Eric (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Nutrition
Gene Editing
Genetic Therapy
Obesity
CRISPR-Cas Systems
Texto completo:http://hdl.handle.net/10400.22/14437
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/14437

Texto Completo

http://hdl.handle.net/10400.22/14437

Registos relacionados